Remdesivir investigational trials in COVID-19: a critical reappraisal. REVISED v2
Cargando...
Fecha
Fecha
2020
Autores
Director de trabajo de grado
Título de la revista
ISSN de la revista
Título del volumen
Editor
New Microbes and New Infections
Resumen
A lot of effort are generally made by the industry during outbreak to promote clinical trials with new drugs. Here we review evidence of the 10 most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention.
Descripción
Palabras clave
Investigational trials, COVID-19, Critical reappraisal, REVISED v2